Notably, miR-233 is highly expressed in gastric cancer and promotes cell proliferation and invasion by targeting EPB41L3 [38]; and overexpression of miR-223 was found to correlate with tumor metastasis and poor prognosis in patients with colorectal cancer and plays an oncogenic role [39, 40]. Here, EPB41L3 is linked to neoplasm.